MSB 1.34% $1.51 mesoblast limited

2023 The Final Countdown, page-1975

  1. 95 Posts.
    lightbulb Created with Sketch. 48
    Fair enough comment. No one should ever gamble anything they can’t afford to lose.

    Each to their own, in the case of their investment strategy.

    There aren’t many companies where at $1B market cap could still give investors a 200x return over 10 years and be so beneficial for society. This is one of those rare o”companies. That explains why many posters are so enthusiastic and passionately supporting it. I do, though I’ve chosen to remain silent and let some key posters be heard from the noise.

    DYOR research. Many here have. I’m willing to take a gamble on this one….

    NB: Two observations to ponder.
    (1) Krause does not make it to the levels he did in the FDA without forming strong relationships and networks of support…..and he’s buying shares.
    (2) Posters like whytee and Croc Doc McMuffin spend most of their time on this chat bagging the company and ‘warning’ investors of the dangers…even in the quieter months prior when it was a waiting game and the share price was going nowhere, as expected. Why? Probably to accumulate when weak hands sell.

    The share price is rising now. It will continue to rise in anticipation of the FDA decision. The ruling could likely fall after 2nd August. I’m sticking this one out….I can afford to lose what I’ve put in. I don’t believe I will though.

    Good luck all holders!!!!


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.